Literature DB >> 15264053

Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study.

Elisabetta Esposito1, Enea Menegatti, Rita Cortesi.   

Abstract

The basic properties and the in vitro release rate kinetics of azelaic acid (AA), alternatively vehiculated in different phospholipid-based vesicles such as ethosomes or liposomes, were investigated. Ethosomes were produced by a simple method based on addition of an aqueous phase to an ethanol solution (comprised between 20\% and 45%, v/v) of soy phosphatidyl choline (5%, w/w) and AA (0.2%, w/w) under mechanical stirring. Liposomes were obtained by the same composition in the absence of ethanol with the reverse-phase evaporation method. Vesicle size was measured by photon correlation spectroscopy (PCS), evidencing smaller mean diameters and narrower dimensional distributions in the case of ethosomes with respect to liposomes. In order to obtain homogeneously sized vesicles, both ethosomal and liposomal dispersions were extruded through polycarbonate membranes with pores of calibrated diameter (400 nm and 200 nm). Vesicle morphology was characterized by freeze-fracture scanning electron microscopy (SEM) showing the presence of unilamellar vesicles both in liposome- and in ethosome-based dispersions. Free energy measurements of the vesicle bilayers were conducted by differential scanning calorimetry (DSC). AA diffusion from ethosomal or liposomal dispersions and from ethosomes and liposomes incorporated in a viscous gel was investigated by a Franz cell assembled with synthetic membranes. The release rate was more rapid from ethosomal systems than from liposomal systems. In particular, ethosomes produced by the highest ethanol concentration released AA more rapidly, and the same trend was found using viscous forms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15264053

Source DB:  PubMed          Journal:  J Cosmet Sci        ISSN: 1525-7886            Impact factor:   0.948


  10 in total

1.  Pouch drug delivery systems for dermal and transdermal administration.

Authors:  Jana Zailer; Elka Touitou
Journal:  Drug Deliv Transl Res       Date:  2014-12       Impact factor: 4.617

2.  Therapeutic and cosmeceutical potential of ethosomes: An overview.

Authors:  Poonam Verma; K Pathak
Journal:  J Adv Pharm Technol Res       Date:  2010-07

Review 3.  Progress in Psoriasis Therapy via Novel Drug Delivery Systems.

Authors:  Nitha Vincent; Devi D Ramya; Hari Bn Vedha
Journal:  Dermatol Reports       Date:  2014-09-08

Review 4.  Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials.

Authors:  Ibrahim M Abdulbaqi; Yusrida Darwis; Nurzalina Abdul Karim Khan; Reem Abou Assi; Arshad A Khan
Journal:  Int J Nanomedicine       Date:  2016-05-25

5.  Stability study of azelaic acid proethosomes with lyoprotectant as stabilizer.

Authors:  Hervianti Nurfitria Nugrahani
Journal:  J Adv Pharm Technol Res       Date:  2018 Apr-Jun

Review 6.  Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties.

Authors:  Hiba Natsheh; Elka Touitou
Journal:  Molecules       Date:  2020-06-27       Impact factor: 4.411

7.  Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery.

Authors:  Dinesh Kumar; Deepak Sharma; Gurmeet Singh; Mankaran Singh; Mahendra Singh Rathore
Journal:  ISRN Pharm       Date:  2012-07-19

8.  Colloidal dispersions for the delivery of acyclovir: a comparative study.

Authors:  Rita Cortesi; Laura Ravani; Enea Menegatti; M Drechsler; Elisabetta Esposito
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975

9.  Identification of unknown impurity of azelaic acid in liposomal formulation assessed by HPLC-ELSD, GC-FID, and GC-MS.

Authors:  Stanisław Han; Katarzyna Karłowicz-Bodalska; Piotr Potaczek; Adam Wójcik; Lukasz Ozimek; Dorota Szura; Witold Musiał
Journal:  AAPS PharmSciTech       Date:  2013-10-29       Impact factor: 3.246

Review 10.  Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions.

Authors:  Elka Touitou; Hiba Natsheh
Journal:  Pharmaceutics       Date:  2021-12-10       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.